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EDITORIAL
THE LATEST ACHIEVEMENTS IN DIAGNOSTICS AND THERAPY 
– THE ERA OF GLOBAL ANALYTICAL METHODS
Šime Spaventi and Zvonko Kusić
The symposium entitled The Latest Achievements in Diagnostics and Therapy – The 
Era of Global Analytical Methods was organised on the occasion of the 40th anniversary 
since the founding of the Cabinet for the Research and Standardization of Immu-
nological Substances, which was established four decades ago by Drago Ikić, Fellow 
of the Croatian Academy (F.C.A.), and is currently active within the Department 
of Medical Sciences of the Croatian Academy of Sciences and Arts. Apart from the 
Academy Department of Medical Sciences, co-organisers of the symposium were 
the Division of Molecular Medicine of the Ruđer Bošković Institute from Zagreb 
and the Department of Biotechnology of the University of Rijeka, which emphasises 
both the importance of the Cabinet and the long and successful co-operation among 
several Croatian scientific and educational institutions active in the field of immu-
nological research.
As early as over forty years ago, Prof. Dr. Drago Ikić recognised the importance 
of immunology. In 1970, wishing to further strengthen the already existing co-ope-
ration between the Department of Medical Sciences of the Croatian Academy of 
Sciences and Arts and the Institute of Immunology, then headed by him, Prof. Dr. 
Ikić initiated the forming of, first, the Section, and later, the Committee for Biological 
Substances.
The Institute for the Research and Standardization of Immunological Substan-
ces was founded within the Research Centre of the Croatian Academy of Sciences 
and Arts in 1982; in the same year, it became the Inter-Academic Committee for Bi-
ological Substances. The same Inter-Academic Committee ceased to be active as the 
Croatian war of Independence broke out in 1991; three years later, the Institute was 
transformed into the Cabinet for the Research and Standardization of Immunologi-
cal Substances within the Department of Medical Sciences of the Croatian Academy 
of Sciences and Arts. The very existence of the Cabinet should primarily be credited 
to Drago Ikić, F.C.A.
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As early as in the late 1970s, Drago Ikić, F.C.A., as the head of the Institute of 
Immunology, was among the first scientists in Europe to begin both producing the 
Interferon and successfully conducting the projects of its application in the adjuvant 
treatment of skin tumours. This activity was facilitated thanks to the fruitful co-
operation between the Cabinet and the Department of Oncology and Nuclear Me-
dicine of the Sestre milosrdnice University Hospital, headed by Šime Spaventi, F.C.A., 
and it served to lay the groundwork for applying immunotherapy in the treatment 
of the said diseases. As a result of this co-operation, other types of immunotherapy 
in the treatment of malignant diseases were applied simultaneously at the Depar-
tment of Oncology and Nuclear Medicine and worldwide; these were the non-spe-
cific immuno-therapeutic agents: BCG, Levamisol and Corynebacterium parvum. 
In 1982, within the said projects, the Centre for Clinical and Experimental Immuno-
logy, with Dragan Dekaris and Vlatko Silobrčić from the Institute of Immunology, 
both Fellows of the Croatian Academy, as advisers, was established as a part of the 
Department of Oncology and Nuclear Medicine. The result thereof was the realisa-
tion of successful co-operation with relevant European organisations, under the pa-
tronage of which immunotherapy-related projects (particularly those dealing with 
melanoma treatment) are conducted. The current Reference Centre for Melanoma of 
the Department of Oncology and Nuclear Medicine and the Dermatovenerological 
Department of the Sestre milosrdnice University Hospital is partly based on the work 
of Drago Ikić, F.C.A., and his Cabinet.
Thanks to the vision and the activity of Drago Ikić, F.C.A., which were reco-
gnised and accepted by his associates, it was made possible for the immunological 
substances – following the research and the standardization – to be applied, first in 
medical research, and subsequently in standard clinical practice, within the shortest 
possible period of time.
In the period between 1968 and 1979, Prof. Dr. Ikić had organised twelve inter-
national symposia in Zagreb in co-operation between the then Yugoslav Academy 
of Sciences and Arts and the Institute of Immunology, which addressed immunolo-
gical topics: several symposia on the Interferon; a symposium on vaccines against 
morbilli, poliomyelitis and pertussis; a symposium on combination vaccines; a sym-
posium on the vaccine against influenza; etc. Together with the world Health Orga-
nization experts, many distinguished international professionals participated in the 
work of the said symposia as well. In the early days of discovering and researching 
the vaccines that are today applied routinely, the Zagreb symposia had significantly 
contributed to improving scientific knowledge in the field of immunology.
The topic addressed at the first international symposium held in 1963, as well 
as the one held in 1968 and the fifth held in 1970, were human diploid cells, wI-38 
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(Hayflick Moorhead 1961), as a new viral vaccines production substrate. The viral 
vaccines production substrate is as important as the vaccinal virus itself. Following 
the conduct of versatile laboratory and epidemiological research, Croatia was the 
first country in the world to adopt, in 1963, human diploid cells for routine, mass 
production and application of live attenuated oral vaccine against poliomyelitis 
(Koprowski strain). Slovenia adopted the said vaccine against poliomyelitis in 1966. 
Subsequent long-lasting and versatile research done regarding the live attenuated 
vaccine against morbilli for parenteral application confirmed that human diploid ce-
lls contain no latent, concealed, hazardous agents, and that they facilitate the multi-
plication of stabile vaccinal anti-morbilli viruses of high concentration. This lead to 
the introduction of attenuated vaccine against morbilli, (Edmonston-Zagreb strain 
1968), intended for mass parenteral application in Croatia; subsequently, other live 
attenuated viral vaccines were introduced as well. Thereby, Croatia adopted, reco-
gnised and levelled human diploid cells (serially multiplied) with animal primary 
cells (not serially multiplied) in the production and the application of live attenuated 
vaccines, both orally and parenterally.
Several years later, the world Health Organization adopted and recognised both 
substrates used for the production and application of viral vaccines.
The greatness of Prof. Dr. Ikić in the field of immunology was recognised and 
saluted by numerous international leading figures. For instance, Hilary Koprowski, 
the director of the wistar Institute from Philadelphia – the first institute for bio-
medical research in the USA, one of the most prominent scientists in biomedicine 
and the founder of the peroral vaccine against poliomyelitis, gives tribute and ac-
knowledgement to Prof. Dr. Ikić for having worked for years on human diploid cells 
and the viruses multiplied in this substrate, and for having gathered all the results 
relevant for basing our confidence in these cells upon (1968).
The world Health Organization recognised the Edmonston-Zagreb vaccine aga-
inst morbilli, in the creation of which Prof. Dr. Ikić had participated, and widely re-
commended it as superior to other vaccines for children under eight months of age.
June K. Robinson, one of the most distinguished American scientists in the field 
of melanoma, points out the pioneer role of Prof. Dr. Ikić and his associates in the 
clinical application of the Interferon in the treatment of skin tumours (1998).
we have decided to mark the 40th anniversary since the founding of the Ca-
binet for the Research and Standardization of Immunological Substances and its 
entering new premises by organising a symposium addressing two topics, which 
are currently probably the ones of the most topical interest in medical science: the 
possibilities of high-throughput genome and proteome analyses in the diagnostics 
of today; and the achievements of cell- and regenerative medicine. The European 
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Medical Research Council – ESF, rather intensively deals with these two topics, whi-
ch are moreover included in the programme of the strategic development of biome-
dicine in the next ten-year period (white Paper Present Status and Future Strategy of 
Medical Research in Europe). Some of the lecturers at the symposium also participate 
in the co-ordination and realisation of the following two European projects: Stem 
Cells and Regenerative Medicine and Preventive Medicine and Global Methods of Genome 
and Proteome Analysis.
we sincerely hope to have managed both to mark this rather significant anni-
versary of the Cabinet for the Research and Standardization of Immunological Su-
bstances in a worthily manner by having held this Symposium, and to continue – by 
choosing discussing points of topical interest – the activities of the Department of 
Medical Sciences of the Croatian Academy of Sciences and Arts, which place this 
body directly into the focus of the state-of-the-art biomedical research.
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